Latest News about ELVN
Recent news which mentions ELVN
From Benzinga
From Benzinga
Greenbrier, RPM International, CVRx And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
April 08, 2025
From Benzinga
This Alumis Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
October 31, 2024
From Benzinga
Enliven Therapeutics' Leukemia Candidate Could Challenge Pfizer, AstraZeneca In Broader Target Market: Analyst
September 09, 2024
From Benzinga
ELVN Stock Earnings: Enliven Therapeutics Beats EPS for Q2 2024
August 13, 2024
Tickers
ELVN
From InvestorPlace
Tickers
ELVN
From InvestorPlace
From Benzinga
Why Fastenal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
April 11, 2024
From Benzinga
Enliven Therapeutics, Alpine Immune Sciences, Janux Therapeutics And Other Big Stocks Moving Higher On Thursday
April 11, 2024
From Benzinga
From Benzinga
Why Peraso Shares Are Trading Lower By Over 23%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
March 19, 2024
From Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
March 19, 2024
From Benzinga
National CineMedia Reports Upbeat Results, Joins Nordstrom, Core & Main And Other Big Stocks Moving Higher On Tuesday
March 19, 2024
From Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
March 19, 2024
From Benzinga
Tickers
ELVN
From InvestorPlace
12 Health Care Stocks Moving In Monday's After-Market Session
February 26, 2024
From Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
January 16, 2024
From Benzinga
7 A-Rated Biotech Stocks for Your August Buy List
August 17, 2023
From InvestorPlace
From Benzinga
7 Biotech Stocks Sitting in the Sweet Spot
March 24, 2023
From InvestorPlace
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.